Incident and recurrent herpes zoster for first-line bDMARD and tsDMARD users in seropositive rheumatoid arthritis patients: a nationwide cohort study

Incident and recurrent herpes zoster for first-line bDMARD and tsDMARD users in seropositive rheumatoid arthritis patients: a nationwide cohort study

Abstract Background There is limited information regarding disease-modifying antirheumatic drug (DMARD)-dependent risks of overall, incident, and recurrent herpes zoster (HZ) during first-line biologic DMARD (bDMARD) or targeted synthetic DMARD (tsDMARD) treatment among patients with seropositive rh...

Full description

Bibliographic Details
Main Authors: Seogsong Jeong, Seulggie Choi, Sang Min Park, Jinseok Kim, Byeongzu Ghang, Eun Young Lee
Format: Article
Language:English
Published: BMC 2022-07-01
Series:Arthritis Research & Therapy
Subjects:
Herpes zoster
Rheumatoid arthritis
Biologic disease-modifying antirheumatic drugs
Targeted synthetic disease-modifying antirheumatic drugs
Online Access:https://doi.org/10.1186/s13075-022-02871-1

Internet

https://doi.org/10.1186/s13075-022-02871-1

Similar Items